Yes, medical cannabis can help reduce seizures in some forms of epilepsy. The most compelling evidence is for rare, childhood-onset syndromes like Dravet and Lennox-Gastaut, where the FDA has approved a purified CBD drug called Epidiolex. However, cannabis is not a first-line treatment for most epilepsy types, and it is not a cure. Instead, it is used as an add-on therapy when traditional medications fail.
For patients and families curious about cannabis medicine, it helps to separate the active components, the research behind them, and the practical realities of using a plant that still faces legal barriers in many places. This guide walks through each piece.
How Cannabis May Reduce Seizures
The cannabis plant contains over a hundred cannabinoids, but the two you hear most about are THC (the intoxicating compound) and CBD (non-intoxicating). For epilepsy, CBD is the workhorse. It does not make you high. Research suggests that CBD interacts with the body's endocannabinoid system, plus other ion channels like sodium and calcium pathways, to calm overexcited nerve signals in the brain. That overexcitation is what sets off a seizure.
THC has anticonvulsant properties in animal studies too, but it causes sedation and psychoactive effects, making it less attractive. Most medical cannabis products for epilepsy are CBD-dominant with only a trace of THC.
Top 3 Medical Cannabis Research Studies for Epilepsy
The Evidence: What Studies Show
The strongest data comes from placebo-controlled trials of Epidiolex, a pharmaceutical-grade CBD. In one trial of children with Dravet syndrome, seizure frequency dropped by about 39% among those taking CBD, versus 17% on placebo. Similar results were seen in Lennox-Gastaut patients. This evidence led the FDA to approve Epidiolex in 2018, and it is now a controlled schedule V drug in the US.
Beyond those two specific syndromes, clinical trials for other epilepsy types have been inconsistent. A 2019 Cochrane review concluded that CBD is effective against Dravet and Lennox-Gastaut, but there is not enough evidence for other epilepsies. Whole-plant cannabis products - like oils, edibles, and flower - have not undergone the same rigorous testing. What we know about them is mostly anecdotal or from small observational registries, which are promising but less reliable.
CBD-Dominant vs. Whole-Plant Products
If you are exploring medical cannabis, you will see two categories:
- Pharmaceutical CBD (Epidiolex) – purified, oral solution, FDA-approved for severe forms. It is consistent and tested, but requires a prescription, not a dispensary visit.
- Dispensary cannabis products – broad-spectrum CBD, full-spectrum CBD, 1:1 CBD:THC oils, and high-CBD flower. These are not FDA-approved for epilepsy. They may contain varying levels of other cannabinoids, terpenes, and even heavy metals depending on the grower.
Some patients report that whole-plant extract works better than purified CBD, a concept called the "entourage effect." That remains unproven. If you do go the dispensary route, ask for laboratory-tested products with a Certificate of Analysis and a clear CBD-to-THC ratio. Start low and go slow, under the guidance of a neurologist.
Risks and Side Effects
CBD is generally well-tolerated, but it is not without side effects. The most common include sleepiness, diarrhea, decreased appetite, and elevated liver enzymes. Importantly, CBD interacts with many anti-seizure medications, particularly clobazam, by inhibiting the liver's CYP450 enzymes. This can raise levels of your other drugs to dangerous highs. That is why you must work with a doctor who can adjust your existing medication doses and run liver function tests.
THC, especially at higher doses, carries more risk: it can worsen seizures in rare cases, causes cognitive impairment, and is problematic for children. Older, neurologically fragile patients are also more sensitive to its psychoactive effects.
Legal Access in the United States
Epidiolex is legal in all 50 states as a prescription drug. For dispensary cannabis, legal status varies by state. Some states allow medical cannabis for epilepsy with a doctor's certification, others have broader medical programs, and adults 21+ can access recreational cannabis in other states. Still, federal law classifies cannabis as a Schedule I substance, which creates obstacles for research and banking but does not usually stop state-legal purchases. Crossing state lines with cannabis is illegal even if both states allow it.
If you are considering medical cannabis, start by talking to your neurologist. They may be hesitant—many are because the evidence base is narrow—but can refer you to a specialist who understands cannabis. You will need to register with your state's medical cannabis program, if one exists, and get a certification. Then you can purchase from a licensed dispensary like Eden Cannabis. Keep a seizure diary to track whether the product is helping.
The bottom line: medical cannabis is a real, evidence-backed option for specific epilepsy syndromes, not a panacea. Do your research, involve your healthcare team, and choose lab-tested products.